ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesenchymal Stem Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-17E231
Home | Market Reports | Science| Biological Sciences
Global Mesenchymal Stem Cells Market Size Status and Forecast 2022
BUY CHAPTERS

Global Mesenchymal Stem Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-17E231
Report
June 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience

Mesenchymal Stem Cells Market Size

In 2024, the global market size of Mesenchymal Stem Cells was estimated to be worth US$ 226 million and is forecast to reach approximately US$ 306 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

Mesenchymal Stem Cells Market

Mesenchymal Stem Cells Market

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
The top 3 manufacturters of Mesenchymal Stem Cells include ​Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.
The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesenchymal Stem Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Mesenchymal Stem Cells Market Report

Report Metric Details
Report Name Mesenchymal Stem Cells Market
Forecasted market size in 2031 approximately US$ 306 million
CAGR 4.5%
Forecasted years 2025 - 2031
Segment by Type
  • Human MSC
  • Mouse MSC
  • Rat MSC
  • Others
Segment by Application
  • Research Institute
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cell Applications, Cyagen Biosciences, Axol Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Mesenchymal Stem Cells in global and regional level.
  • Chapter 3: Detailed analysis of Mesenchymal Stem Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mesenchymal Stem Cells revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Mesenchymal Stem Cells Market size in 2031?

Ans: The Mesenchymal Stem Cells Market size in 2031 will be approximately US$ 306 million.

What is the market share of major companies in Mesenchymal Stem Cells Market?

Ans: The top 3 manufacturters of Mesenchymal Stem Cells include ​Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.

What is the Mesenchymal Stem Cells Market share by region?

Ans: North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.

Who are the main players in the Mesenchymal Stem Cells Market report?

Ans: The main players in the Mesenchymal Stem Cells Market are Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cell Applications, Cyagen Biosciences, Axol Bioscience

What are the Application segmentation covered in the Mesenchymal Stem Cells Market report?

Ans: The Applications covered in the Mesenchymal Stem Cells Market report are Research Institute, Hospital, Others

What are the Type segmentation covered in the Mesenchymal Stem Cells Market report?

Ans: The Types covered in the Mesenchymal Stem Cells Market report are Human MSC, Mouse MSC, Rat MSC, Others

1 Study Coverage
1.1 Mesenchymal Stem Cells Product Introduction
1.2 Market by Type
1.2.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Human MSC
1.2.3 Mouse MSC
1.2.4 Rat MSC
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Research Institute
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Mesenchymal Stem Cells Market Size Estimates and Forecasts
2.2 Mesenchymal Stem Cells Market Size by Region: 2024 Versus 2031
2.2.1 Global Mesenchymal Stem Cells Revenue by Region: 2020-2025
2.2.2 Global Mesenchymal Stem Cells Revenue Forecast by Region (2026-2031)
2.2.3 Global Mesenchymal Stem Cells Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Mesenchymal Stem Cells Revenue by Type (2020-2031)
3.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Mesenchymal Stem Cells Revenue by Application (2020-2031)
3.2.2 Global Mesenchymal Stem Cells Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Human MSC of Mesenchymal Stem Cells Revenue Market Share by Application
3.3.2 Mouse MSC of Mesenchymal Stem Cells Revenue Market Share by Application
3.3.3 Rat MSC of Mesenchymal Stem Cells Revenue Market Share by Application
3.3.4 Others of Mesenchymal Stem Cells Revenue Market Share by Application
4 Global Mesenchymal Stem Cells by Company
4.1 Global Mesenchymal Stem Cells Revenue by Company (2020-2025)
4.2 Global Mesenchymal Stem Cells Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Mesenchymal Stem Cells Companies around the World: Ranking by Revenue
4.3.2 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Mesenchymal Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Mesenchymal Stem Cells Companies Headquarters & Product Type
4.4.1 Global Mesenchymal Stem Cells Companies Headquarters
4.4.2 Date of International Companies Enter into Mesenchymal Stem Cells Market
4.4.3 Global Mesenchymal Stem Cells Companies Product & Service
4.4.4 Human MSC Revenue Market Share of Mesenchymal Stem Cells by Company
4.4.5 Mouse MSC Revenue Market Share of Mesenchymal Stem Cells by Company
4.4.6 Rat MSC Revenue Market Share of Mesenchymal Stem Cells by Company
4.4.7 Others Revenue Market Share of Mesenchymal Stem Cells by Company
4.5 Global Mesenchymal Stem Cells Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Lonza
5.1.1 Lonza Corporation Information
5.1.2 Lonza Description, Business Overview
5.1.3 Lonza Mesenchymal Stem Cells Products Offered
5.1.4 Lonza Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.1.5 Lonza Mesenchymal Stem Cells Revenue by Product in 2024
5.1.6 Lonza Mesenchymal Stem Cells Revenue by Application in 2024
5.1.7 Lonza Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.1.8 Lonza Recent Developments
5.2 Thermo Fisher
5.2.1 Thermo Fisher Corporation Information
5.2.2 Thermo Fisher Description, Business Overview
5.2.3 Thermo Fisher Mesenchymal Stem Cells Products Offered
5.2.4 Thermo Fisher Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.2.5 Thermo Fisher Mesenchymal Stem Cells Revenue by Product in 2024
5.2.6 Thermo Fisher Mesenchymal Stem Cells Revenue by Application in 2024
5.2.7 Thermo Fisher Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.2.8 Thermo Fisher Recent Developments
5.3 Bio-Techne
5.3.1 Bio-Techne Corporation Information
5.3.2 Bio-Techne Description, Business Overview
5.3.3 Bio-Techne Mesenchymal Stem Cells Products Offered
5.3.4 Bio-Techne Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.3.5 Bio-Techne Mesenchymal Stem Cells Revenue by Product in 2024
5.3.6 Bio-Techne Mesenchymal Stem Cells Revenue by Application in 2024
5.3.7 Bio-Techne Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.3.8 Bio-Techne Recent Developments
5.4 ATCC
5.4.1 ATCC Corporation Information
5.4.2 ATCC Description, Business Overview
5.4.3 ATCC Mesenchymal Stem Cells Products Offered
5.4.4 ATCC Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.4.5 ATCC Mesenchymal Stem Cells Revenue by Product in 2024
5.4.6 ATCC Mesenchymal Stem Cells Revenue by Application in 2024
5.4.7 ATCC Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.4.8 ATCC Recent Developments
5.5 MilliporeSigma
5.5.1 MilliporeSigma Corporation Information
5.5.2 MilliporeSigma Description, Business Overview
5.5.3 MilliporeSigma Mesenchymal Stem Cells Products Offered
5.5.4 MilliporeSigma Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.5.5 MilliporeSigma Mesenchymal Stem Cells Revenue by Product in 2024
5.5.6 MilliporeSigma Mesenchymal Stem Cells Revenue by Application in 2024
5.5.7 MilliporeSigma Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.5.8 MilliporeSigma Recent Developments
5.6 PromoCell GmbH
5.6.1 PromoCell GmbH Corporation Information
5.6.2 PromoCell GmbH Description, Business Overview
5.6.3 PromoCell GmbH Mesenchymal Stem Cells Products Offered
5.6.4 PromoCell GmbH Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.6.5 PromoCell GmbH Mesenchymal Stem Cells Revenue by Product in 2024
5.6.6 PromoCell GmbH Mesenchymal Stem Cells Revenue by Application in 2024
5.6.7 PromoCell GmbH Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.6.8 PromoCell GmbH Recent Developments
5.7 Genlantis
5.7.1 Genlantis Corporation Information
5.7.2 Genlantis Description, Business Overview
5.7.3 Genlantis Mesenchymal Stem Cells Products Offered
5.7.4 Genlantis Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.7.5 Genlantis Mesenchymal Stem Cells Revenue by Product in 2024
5.7.6 Genlantis Mesenchymal Stem Cells Revenue by Application in 2024
5.7.7 Genlantis Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.7.8 Genlantis Recent Developments
5.8 Celprogen
5.8.1 Celprogen Corporation Information
5.8.2 Celprogen Description, Business Overview
5.8.3 Celprogen Mesenchymal Stem Cells Products Offered
5.8.4 Celprogen Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.8.5 Celprogen Mesenchymal Stem Cells Revenue by Product in 2024
5.8.6 Celprogen Mesenchymal Stem Cells Revenue by Application in 2024
5.8.7 Celprogen Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.8.8 Celprogen Recent Developments
5.9 Cell Applications
5.9.1 Cell Applications Corporation Information
5.9.2 Cell Applications Description, Business Overview
5.9.3 Cell Applications Mesenchymal Stem Cells Products Offered
5.9.4 Cell Applications Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.9.5 Cell Applications Mesenchymal Stem Cells Revenue by Product in 2024
5.9.6 Cell Applications Mesenchymal Stem Cells Revenue by Application in 2024
5.9.7 Cell Applications Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.9.8 Cell Applications Recent Developments
5.10 Cyagen Biosciences
5.10.1 Cyagen Biosciences Corporation Information
5.10.2 Cyagen Biosciences Description, Business Overview
5.10.3 Cyagen Biosciences Mesenchymal Stem Cells Products Offered
5.10.4 Cyagen Biosciences Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.10.5 Cyagen Biosciences Mesenchymal Stem Cells Revenue by Product in 2024
5.10.6 Cyagen Biosciences Mesenchymal Stem Cells Revenue by Application in 2024
5.10.7 Cyagen Biosciences Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.10.8 Cyagen Biosciences Recent Developments
5.11 Axol Bioscience
5.11.1 Axol Bioscience Corporation Information
5.11.2 Axol Bioscience Description, Business Overview
5.11.3 Axol Bioscience Mesenchymal Stem Cells Products Offered
5.11.4 Axol Bioscience Mesenchymal Stem Cells Revenue and Gross Margin (2020-2025)
5.11.5 Axol Bioscience Mesenchymal Stem Cells Revenue by Product in 2024
5.11.6 Axol Bioscience Mesenchymal Stem Cells Revenue by Application in 2024
5.11.7 Axol Bioscience Mesenchymal Stem Cells Revenue by Geographic Area in 2024
5.11.8 Axol Bioscience Recent Developments
6 North America
6.1 North America Mesenchymal Stem Cells Market Size YoY Growth 2020-2031
6.2 North America Mesenchymal Stem Cells Market Facts & Figures by Country (2020-2031)
6.3 North America Mesenchymal Stem Cells Revenue by Type (2020-2025)
6.4 North America Mesenchymal Stem Cells Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Mesenchymal Stem Cells Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Mesenchymal Stem Cells Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Mesenchymal Stem Cells Revenue by Type (2020-2025)
7.4 Asia-Pacific Mesenchymal Stem Cells Revenue by Application (2020-2025)
8 Europe
8.1 Europe Mesenchymal Stem Cells Market Size YoY Growth 2020-2031
8.2 Europe Mesenchymal Stem Cells Market Facts & Figures by Country (2020-2031)
8.3 Europe Mesenchymal Stem Cells Revenue by Type (2020-2025)
8.4 Europe Mesenchymal Stem Cells Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Mesenchymal Stem Cells Market Size YoY Growth 2020-2031
9.2 Latin America Mesenchymal Stem Cells Market Facts & Figures by Country (2020-2031)
9.3 Latin America Mesenchymal Stem Cells Revenue by Type (2020-2025)
9.4 Latin America Mesenchymal Stem Cells Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Mesenchymal Stem Cells Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Mesenchymal Stem Cells Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Mesenchymal Stem Cells Revenue by Type (2020-2025)
10.4 Middle East and Africa Mesenchymal Stem Cells Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Mesenchymal Stem Cells Supply Chain Analysis
11.2 Mesenchymal Stem Cells Key Raw Materials and Upstream Suppliers
11.3 Mesenchymal Stem Cells Clients Analysis
11.4 Mesenchymal Stem Cells Sales Channel and Sales Model Analysis
11.4.1 Mesenchymal Stem Cells Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Mesenchymal Stem Cells Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Mesenchymal Stem Cells Distributors
12 Mesenchymal Stem Cells Market Dynamics
12.1 Mesenchymal Stem Cells Industry Trends
12.2 Mesenchymal Stem Cells Market Drivers
12.3 Mesenchymal Stem Cells Market Challenges
12.4 Mesenchymal Stem Cells Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
List of Tables
 Table 1. Global Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Mesenchymal Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Mesenchymal Stem Cells Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Mesenchymal Stem Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Mesenchymal Stem Cells Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Mesenchymal Stem Cells Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Mesenchymal Stem Cells Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Mesenchymal Stem Cells Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Mesenchymal Stem Cells Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Mesenchymal Stem Cells Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Mesenchymal Stem Cells Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Mesenchymal Stem Cells Players by Revenue (US$ Million) in 2024
 Table 13. Global Mesenchymal Stem Cells Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Mesenchymal Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cells as of 2024)
 Table 15. Global Mesenchymal Stem Cells Companies Headquarters
 Table 16. Date of International Companies Enter into Mesenchymal Stem Cells Market
 Table 17. Global Mesenchymal Stem Cells Companies Product & Service
 Table 18. Global Mesenchymal Stem Cells Mergers & Acquisitions, Expansion Plans
 Table 19. Lonza Corporation Information
 Table 20. Lonza Description and Business Overview
 Table 21. Lonza Mesenchymal Stem Cells Product
 Table 22. Lonza Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Lonza Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 24. Lonza Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 25. Lonza Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 26. Lonza Recent Developments
 Table 27. Thermo Fisher Corporation Information
 Table 28. Thermo Fisher Description and Business Overview
 Table 29. Thermo Fisher Mesenchymal Stem Cells Product
 Table 30. Thermo Fisher Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Thermo Fisher Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 32. Thermo Fisher Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 33. Thermo Fisher Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 34. Thermo Fisher Recent Developments
 Table 35. Bio-Techne Corporation Information
 Table 36. Bio-Techne Description and Business Overview
 Table 37. Bio-Techne Mesenchymal Stem Cells Product
 Table 38. Bio-Techne Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Bio-Techne Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 40. Bio-Techne Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 41. Bio-Techne Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 42. Bio-Techne Recent Developments
 Table 43. ATCC Corporation Information
 Table 44. ATCC Description and Business Overview
 Table 45. ATCC Mesenchymal Stem Cells Product
 Table 46. ATCC Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. ATCC Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 48. ATCC Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 49. ATCC Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 50. ATCC Recent Developments
 Table 51. MilliporeSigma Corporation Information
 Table 52. MilliporeSigma Description and Business Overview
 Table 53. MilliporeSigma Mesenchymal Stem Cells Product
 Table 54. MilliporeSigma Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. MilliporeSigma Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 56. MilliporeSigma Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 57. MilliporeSigma Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 58. MilliporeSigma Recent Developments
 Table 59. PromoCell GmbH Corporation Information
 Table 60. PromoCell GmbH Description and Business Overview
 Table 61. PromoCell GmbH Mesenchymal Stem Cells Product
 Table 62. PromoCell GmbH Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. PromoCell GmbH Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 64. PromoCell GmbH Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 65. PromoCell GmbH Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 66. PromoCell GmbH Recent Developments
 Table 67. Genlantis Corporation Information
 Table 68. Genlantis Description and Business Overview
 Table 69. Genlantis Mesenchymal Stem Cells Product
 Table 70. Genlantis Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Genlantis Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 72. Genlantis Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 73. Genlantis Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 74. Genlantis Recent Developments
 Table 75. Celprogen Corporation Information
 Table 76. Celprogen Description and Business Overview
 Table 77. Celprogen Mesenchymal Stem Cells Product
 Table 78. Celprogen Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Celprogen Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 80. Celprogen Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 81. Celprogen Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 82. Celprogen Recent Developments
 Table 83. Cell Applications Corporation Information
 Table 84. Cell Applications Description and Business Overview
 Table 85. Cell Applications Mesenchymal Stem Cells Product
 Table 86. Cell Applications Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Cell Applications Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 88. Cell Applications Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 89. Cell Applications Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 90. Cell Applications Recent Developments
 Table 91. Cyagen Biosciences Corporation Information
 Table 92. Cyagen Biosciences Description and Business Overview
 Table 93. Cyagen Biosciences Mesenchymal Stem Cells Product
 Table 94. Cyagen Biosciences Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Cyagen Biosciences Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 96. Cyagen Biosciences Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 97. Cyagen Biosciences Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 98. Cyagen Biosciences Recent Developments
 Table 99. Axol Bioscience Corporation Information
 Table 100. Axol Bioscience Description and Business Overview
 Table 101. Axol Bioscience Mesenchymal Stem Cells Product
 Table 102. Axol Bioscience Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Axol Bioscience Revenue Proportion of Mesenchymal Stem Cells by Product in 2024
 Table 104. Axol Bioscience Revenue Proportion of Mesenchymal Stem Cells by Application in 2024
 Table 105. Axol Bioscience Revenue Proportion of Mesenchymal Stem Cells by Geographic Area in 2024
 Table 106. Axol Bioscience Recent Developments
 Table 107. North America Mesenchymal Stem Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 108. North America Mesenchymal Stem Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 109. North America Mesenchymal Stem Cells Revenue by Type (2020-2025) & (US$ Million)
 Table 110. North America Mesenchymal Stem Cells Revenue by Application (2020-2025) & (US$ Million)
 Table 111. Asia-Pacific Mesenchymal Stem Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 112. Asia-Pacific Mesenchymal Stem Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 113. Asia-Pacific Mesenchymal Stem Cells Revenue by Type (2020-2025) & (US$ Million)
 Table 114. Asia-Pacific Mesenchymal Stem Cells Revenue by Application (2020-2025) & (US$ Million)
 Table 115. Europe Mesenchymal Stem Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 116. Europe Mesenchymal Stem Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 117. Europe Mesenchymal Stem Cells Revenue by Type (2020-2025) & (US$ Million)
 Table 118. Europe Mesenchymal Stem Cells Revenue by Application (2020-2025) & (US$ Million)
 Table 119. Latin America Mesenchymal Stem Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 120. Latin America Mesenchymal Stem Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 121. Latin America Mesenchymal Stem Cells Revenue by Type (2020-2025) & (US$ Million)
 Table 122. Latin America Mesenchymal Stem Cells Revenue by Application (2020-2025) & (US$ Million)
 Table 123. Middle East and Africa Mesenchymal Stem Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 124. Middle East and Africa Mesenchymal Stem Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 125. Middle East and Africa Mesenchymal Stem Cells Revenue by Type (2020-2025) & (US$ Million)
 Table 126. Middle East and Africa Mesenchymal Stem Cells Revenue by Application (2020-2025) & (US$ Million)
 Table 127. Mesenchymal Stem Cells Key Raw Materials, Industry Status and Trend
 Table 128. Mesenchymal Stem Cells Key Raw Materials and Upstream Suppliers
 Table 129. Mesenchymal Stem Cells Clients Status and Trend
 Table 130. Mesenchymal Stem Cells Typical Clients
 Table 131. Mesenchymal Stem Cells Distributors
 Table 132. Mesenchymal Stem Cells Market Trends
 Table 133. Mesenchymal Stem Cells Market Drivers
 Table 134. Mesenchymal Stem Cells Market Challenges
 Table 135. Mesenchymal Stem Cells Market Restraints
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources


List of Figures
 Figure 1. Mesenchymal Stem Cells Product Picture
 Figure 2. Global Mesenchymal Stem Cells Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Mesenchymal Stem Cells Revenue Market Share by Type in 2024 & 2031
 Figure 4. Human MSC Product Picture
 Figure 5. Mouse MSC Product Picture
 Figure 6. Rat MSC Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Mesenchymal Stem Cells Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Mesenchymal Stem Cells Revenue Market Share by Application in 2024 & 2031
 Figure 10. Research Institute
 Figure 11. Hospital
 Figure 12. Others
 Figure 13. Mesenchymal Stem Cells Report Years Considered
 Figure 14. Global Mesenchymal Stem Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Mesenchymal Stem Cells Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Mesenchymal Stem Cells Market Size Market Share by Region: 2024 Versus 2031
 Figure 17. Global Mesenchymal Stem Cells Revenue Market Share by Region (2020-2031)
 Figure 18. Global Mesenchymal Stem Cells Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Global Mesenchymal Stem Cells Revenue Market Share Forecast by Application (2020-2031)
 Figure 20. Human MSC of Mesenchymal Stem Cells Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Mouse MSC of Mesenchymal Stem Cells Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Rat MSC of Mesenchymal Stem Cells Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Others of Mesenchymal Stem Cells Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Mesenchymal Stem Cells Revenue Share by Company (2024)
 Figure 25. Mesenchymal Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Human MSC Revenue Proportion by Company in 2024
 Figure 27. Mouse MSC Revenue Proportion by Company in 2024
 Figure 28. Rat MSC Revenue Proportion by Company in 2024
 Figure 29. Others Revenue Proportion by Company in 2024
 Figure 30. North America Mesenchymal Stem Cells Revenue 2020-2031 (US$ Million)
 Figure 31. North America Mesenchymal Stem Cells Revenue Market Share by Type (2020-2025)
 Figure 32. North America Mesenchymal Stem Cells Revenue Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Mesenchymal Stem Cells Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Mesenchymal Stem Cells Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Mesenchymal Stem Cells Revenue Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Mesenchymal Stem Cells Revenue Market Share by Application (2020-2025)
 Figure 37. Europe Mesenchymal Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Mesenchymal Stem Cells Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Mesenchymal Stem Cells Revenue Market Share by Type (2020-2025)
 Figure 40. Europe Mesenchymal Stem Cells Revenue Market Share by Application (2020-2025)
 Figure 41. Latin America Mesenchymal Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Mesenchymal Stem Cells Revenue Market Share by Country (2020-2031)
 Figure 43. Latin America Mesenchymal Stem Cells Revenue Market Share by Type (2020-2025)
 Figure 44. Latin America Mesenchymal Stem Cells Revenue Market Share by Application (2020-2025)
 Figure 45. Middle East and Africa Mesenchymal Stem Cells Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Middle East and Africa Mesenchymal Stem Cells Revenue Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Mesenchymal Stem Cells Revenue Market Share by Type (2020-2025)
 Figure 48. Middle East and Africa Mesenchymal Stem Cells Revenue Market Share by Application (2020-2025)
 Figure 49. Mesenchymal Stem Cells Supply Chain (Upstream and Downstream Market)
 Figure 50. Global Production Market Share of Mesenchymal Stem Cells Raw Materials by Region in 2024
 Figure 51. Mesenchymal Stem Cells Distribution Channels
 Figure 52. Global Mesenchymal Stem Cells Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 53. Global Mesenchymal Stem Cells Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Mesenchymal Stem Cell Drugs Market Research Report 2024
Global Mesenchymal Stem Cell Injection Market Research Report 2024
Global Human Mesenchymal Stem Cells hMSC Market Insights Forecast to 2030
Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adipose Tissue Derived Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesenchymal Stem Cell Therapy MSCT Market Research Report 2025
Global Mesenchymal Stem Cell MSC Medium Market Research Report 2025
Global Stem Cell Research Antibodies Market Research Report 2024
Global Adipose Derived Stem Cell Therapy Market Research Report 2024
Global Adipose Tissue derived Stem Cell Therapy Market Research Report 2024
Global Neural Stem Cell Media Market Research Report 2024
Global Stem Cell and Primary Cell Culture Medium Market Insights Forecast to 2030
Progenitor Cell Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Embryonic Stem Cells HESC Market Research Report 2024
Global Stem Cell Services Market Insights Forecast to 2030
Global Mesenchymal Stem Cell Medium Market Research Report 2025
Global Neural Stem Cell Media and Reagents Market Research Report 2024
Global Mesenchymal Stem Cell Media Market Research Report 2024
Placental Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesenchymal Stem Cell MSCs Therapeutic Product CDMO Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions